Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4876 AL 4890

Novel Cellular Signalling Axes in Neurodegenerative Diseases: From NLRP3 Inflammasome to Wnt/β-Catenin and Hippo-YAP Pathways

Singh K, Ahmad I, Jain D, Mim TJ, Noman AA, Shihab MPR, Kondaveeti SB, Gupta JK, Wal P.

J Biochem Mol Toxicol. 2026 May;40(5):e70880. doi: 10.1002/jbt.70880.

Keap1-Nrf2 Signaling Pathway-Mediated Antioxidant Defense in Neurodegenerative Diseases: Mechanisms and Traditional Chinese Medicine Therapeutic Strategies

Chen W, Wang J, Li Q, Zhang L, Wu X, Luo S, Xie Y, Guo P.

Front Biosci (Landmark Ed). 2026 Apr 17;31(4):45233. doi: 10.31083/FBL45233.

Extracellular vesicles as paradigm shifters: Transformative roles in diagnosis and therapy for brain disorders

Puthiyattil N, Varughese D, Mani BM, Babu RS, Nair KS, George RL, Ramitha PA, Dogra N, Mathew M, Varghese MT, Hof PR, Mohanakumar KP, Rajamma U.

Ageing Res Rev. 2026 May 14;119:103178. doi: 10.1016/j.arr.2026.103178. Online ahead of print.

Zebrafish as a Versatile Screening Model for Neurological Diseases: Insights Into Biology, Drug Delivery and Therapeutic Discovery

Vyavahare S, Pawar A, Sayyed SA, Shegar N, Raykar S, Doke R, Singh S.

J Biochem Mol Toxicol. 2026 Mar;40(3):e70750. doi: 10.1002/jbt.70750.

Exploring Neurodegenerative Diseases: Bridging the Gap between in vitro and in vivo Models

El Elhaj A, Onger ME.

Curr Pharm Des. 2026;32(6):407-414. doi: 10.2174/0113816128374254250605070049.

Bridging protein quality control and epigenetic dysregulation: The HDAC6 paradox in neurological disorders and therapeutic targeting

Chen Y, Wu Y, Liu X, Wan J, Shen M, Zhang Q.

Eur J Pharmacol. 2026 Mar 28;1019:178721. doi: 10.1016/j.ejphar.2026.178721. Epub 2026 Mar 3.

Physiological Functions of Side-Chain-Retaining Sterols in the Brain and Their Roles in Neurodegenerative Diseases

Kiriyama Y, Nakatsuma A, Tokumaru H, Sadamoto H, Nochi H.

Metabolites. 2026 Mar 11;16(3):189. doi: 10.3390/metabo16030189.

Gene therapy for huntington's disease: advances, challenges, and future perspectives

Kaushal R, Yadav M, Kosey S, Dwivedi M.

Neurogenetics. 2026 Feb 21;27(1):17. doi: 10.1007/s10048-026-00887-2.

Post-hypoxic chorea, dystonia, and parkinsonism: a case report and literature review

Salari M, Kavianpoor S, Etemadifar M, Rezaei K.

Clin Park Relat Disord. 2026 Feb 19;14:100432. doi: 10.1016/j.prdoa.2026.100432. eCollection 2026.

Insights into phosphoproteomic studies and prospects of phosphoproteins as biomarkers for brain disorders

Le J, Hu X, Jiang Y, Wang Q, Ma Q, Cui W.

J Alzheimers Dis. 2026 Mar;110(1):5-25. doi: 10.1177/13872877251411546. Epub 2026 Jan 13.

Paroxysmal kinesigenic dyskinesia: clinical report of 10 cases from three pedigrees with literature review

Sun Y, Cao H, Wang X.

Neurol Sci. 2026 May 22;47(6):510. doi: 10.1007/s10072-026-09099-w.

Long non-coding RNAs in neurodegenerative diseases - Molecular mechanisms, liquid biopsy biomarkers, and therapeutic targets: A review

Cheng Y, Qiu M, Yu Z, Tang X, Zhang J.

Biomol Biomed. 2026 Mar 31. doi: 10.17305/bb.2026.13978. Online ahead of print.

Relapsing-remitting multiple sclerosis in a patient with Huntington's disease

Appiani FE, Ruiz Miyares FJ, Miraval Marquez FK, Donaire Pedraza AJ.

BMJ Case Rep. 2026 Apr 17;19(4):e269215. doi: 10.1136/bcr-2025-269215.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias